Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,092 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lianas from lives to afterlives: 1st International workshop on liana forest ecology, Xishuangbanna, China, 12-16 October 2023.
Dossa GGO, Adhikari S, Cao KF, Chen YJ, Codjia JEI, Corlett RT, Dong J, Fan ZX, Khatri P, Kiki M, Li HL, Ling TC, Liu G, Majcher BM, Nisar N, Njoroge DM, Ofosu-Bamfo B, Pearce S, Roeder M, Schaefer DA, Schnitzer SA, Smith-Martin CM, Thu WP, Tomlinson KW, Xu SY, Zakari S, Zhang JL, Zhang YB, Zotz G, Zuo J, Cornelissen JHC. Dossa GGO, et al. Among authors: li hl. New Phytol. 2024 Jun;242(5):1886-1890. doi: 10.1111/nph.19729. Epub 2024 Apr 15. New Phytol. 2024. PMID: 38622774 No abstract available.
Effects of lianas on forest biogeochemistry during their lives and afterlives.
Dossa GGO, Li HL, Pan B, Ling TC, Schaefer DA, Roeder M, Njoroge DM, Zuo J, Song L, Ofosu-Bamfo B, Schnitzer SA, Harrison RD, Bongers F, Zhang JL, Cao KF, Powers JS, Fan ZX, Chen YJ, Corlett RT, Zotz G, Oleksyn J, Wyka TP, Codjia JEI, Cornelissen JHC. Dossa GGO, et al. Among authors: li hl. Glob Chang Biol. 2024 Apr;30(4):e17274. doi: 10.1111/gcb.17274. Glob Chang Biol. 2024. PMID: 38605677
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: li hl. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
2,092 results